Connect with us

One-Hit Wonders

Cannabis Foods In Greece: A Blurry Legal Framework

Published

on


Under Greek law, unprocessed products gathered from the cultivation of the Cannabis Sativa L plant which contain tetrahydrocannabinol (THC) at a concentration of less than 0,2%, are not considered to be illegal narcotic drugs. It is noted that in accordance with the new EU Common Agricultural Policy for 2023, it has been announced that this THC concentration level is intended to be increased to 0,3%.

However, the above THC level only concerns the unprocessed product gathered from the Cannabis plant, and not final products intended for consumption. Therefore, it does not mean that Cannabis-derived foods and food supplements containing THC under 0,2% are per se legal under the Greek framework.

In relation to the circulation of foodstuffs (with the exception of children’s foods), food supplements and cosmetics deriving from Cannabis Sativa L, Greek Law has provided that Ministerial Decisions shall be issued which will set the appropriate limits of THC concentration for each category of products, as well as the further requirements for the circulation of such products in the market.

On the one hand, regarding food supplements, a Ministerial Decision was published in June 2022 establishing that Cannabis supplements should not contain THC at a detectable level (i.e. the THC level should be less than 0.0001%). In addition, if the supplements contain ingredients that are “novel foods” (such as cannabidiol – CBD), the relevant authorization of the EU Novel Foods Regulation is first required.

On the other hand, regarding foodstuffs, even though a working group has been set-up at the Greek Ministry of Agriculture and Foods in order to proposethe appropriate THC limits in foods and to draft the necessary provisions that would regulate their legitimate circulation, the relevant Ministerial Decision has not yet been issued. Therefore, the issue of the legitimate circulation, marketing and advertising of “cannabis foods” currently remains a grey legal area.

In addition to the above, it is noted that cannabinoids, including cannabidiol (CBD), which do not have a history of consumption in the EU prior to 1997, fall under the category of “novel foods” and, therefore, their circulation needs first to be authorized according to the relevant EU Regulation 2283/2015. The competent authority regarding novel foods in Greece is the General Chemical Laboratory of the State. In relation to the issue of CBD as a novel food, the European Food Safety Authority (EFSA) published a statement in June 2022, indicating that the safety of CBD for human consumption as a food (not as medicine) cannot currently be established, and that more data will be needed in order to complete the assessment.

At the same time, some products deriving from certain edible natural parts of the Cannabis Sativa L plant, such as seeds, seed oil, seed flour, have been consumed in the EU prior to 1997 according to the EU novel food catalogue, and therefore are not subject to the Novel Foods Regulation (provided that they do not contain other ingredients that are “novel foods”, such as CBD). However, as mentioned above, relevant legal provisions are still expected to be issued in Greece in order to regulate the appropriate THC levels of such “cannabis foods”.

The current situation in the Greek market is that a number of Cannabis foodstuffs (and food supplements) are advertised online and are available for purchase in a growing number of e-shops and physical stores, most of which specialize in selling specifically this category of products.

Nevertheless, it follows from the above that there are still many grey areas regarding the legality of marketing and circulation of Cannabis foods in Greece, under the current, blurry, legal framework.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Source Mondaq

https://www.mondaq.com/unitedstates/cannabis–hemp/1289718/cannabis-foods-in-greece-a-blurry-legal-framework



Source link

Continue Reading

One-Hit Wonders

Alert: December 2024 Cannabis Regulation in Mexico: Navigating the New COFEPRIS Permitting Process Under the Judicial Reform

Published

on

By



Alert: December 2024 Cannabis Regulation in Mexico: Navigating the New COFEPRIS Permitting Process Under the Judicial Reform



Source link

Continue Reading

One-Hit Wonders

Minnesota Office of Cannabis Management Issues Rejections to Majority of Social Equity Applicants

Published

on

By


The Minnesota Office of Cannabis Management (“OCM”) has begun issuing final denials to the overwhelming majority of previously qualified social equity applicants (“SEA”s) ahead of its first statewide cannabis lottery on December 2 for 280 available “preapproval” cannabis licenses.

Flag of Minnesota in Marijuana leaf shape. The concept of legalization Cannabis in Minnesota. Medical cannabis illustration.

Per reporting from MJ Biz Daily, “The applicants who are barred from the lottery failed to complete the application process or acted improperly by submitting multiple applications or disguising the true investors in their companies, according to [OCM].” Obviously applying for more licenses than is allowed and/or concealing owners or financial interests are clear grounds for SEA application rejection. Other alleged “deficiencies” though may not be so cut and dry.

While state law does not permit appeals from denied applicants (which is not uncommon for states with cannabis licensing programs), impacted SEAs can still secure a review of their records submitted to the OCM within seven days of the rejection decision (by logging into their Accela Citizen Portal and pulling the internal record there).

The main issue emerging as a result of these rejections is the fact that the OCM did not consistently issue deficiency notices to rejected applicants if there was a material problem with their submitted applications (although as of October 16, the OCM had sent out deficiency notices to over 300 SEAs). In turn, there are instances here where SEAs were rejected for minor, seemingly non-material deficiencies in their applications (things like submitting incorrect corporate documentation that still contained the same information the OCM sought, or re-submitting documents upon request by the OCM only to be rejected for lack of the same document after-the-fact, or even blank denials altogether with no stated reason for rejection).

In an interview with the Brainerd Dispatch, Charlene Briner, the interim director of the OCM, cast these denied SEA applications into four categories:

  • Failure to meet the basic qualifying standards under state law (i.e., social equity applicant owning at least 65% of the business among others)
  • Failure to provide the requisite verification documents (i.e., legitimate business plans, source of funds, ID, etc.)
  • Hidden or inconsistent ownership or true parties of interest
  • Fraudsters (i.e., those trying to game the system by flooding it with multiple applications via proxy or otherwise by using the same address or phone number tied to the same person on multiple applications)

The first and second bullet points above are going to be the ripest ground for rejected SEAs to try to stop the OCM prior to the December 2 lottery, but that’s only if those rejected SEAs can very quickly obtain copies of their submitted documents (within 7 days of the rejection) and start the administrative litigation process and/or seek injunctive relief at the same time against the OCM.

What was once more than 1800 qualified social equity applicants for the lottery has been winnowed down to around 640. The OCM rejected applicants for a multitude of reasons, some of which are clearly legitimate and some of which appear to be questionably enforceable from the perspective of complying with Minnesota’s state constitution and its administrative procedure act.

If you’ve been impacted by an OCM rejection, you do not have much time to act ahead of the December 2 lottery. If you have questions about your potential civil or administrative claims against OCM due to a questionable SEA rejection, contact Jeffrey O’BrienHilary Bricken, or Nick Morgan.

Minnesota Office of Cannabis Management Issues Rejections to Majority of Social Equity Applicants



Source link

Continue Reading

One-Hit Wonders

Wait? My CBD Business May Be Racketeering? A Potential Existential Crisis We Have Been Warning About

Published

on

By


Even the most responsible hemp operator should understand that it operates in a world full of risk. But I doubt many of them believe they might be accused of racketeering. Last week, the U.S. Supreme Court heard arguments about whether to sanction a commercial trucker’s attempt to bring a racketeering claim against CBD companies, whose allegedly mislabeled products the trucker claims led to his firing.

As always, Sam Reisman at Law360 distills the issue nicely:

The case concerns an allegation that companies sold CBD products with detectable amounts of THC, purportedly costing plaintiff Douglas J. Horn his job as a commercial trucker after he tested positive on a drug test. Oral arguments on Tuesday hinged largely on whether Horn’s claims stemmed from a personal injury — which would be excluded from the Racketeer Influenced and Corrupt Organizations Act, or RICO — or whether his firing was an economic injury and therefore redressable under RICO.

In taking the case, the U.S. Supreme Court could resolve a 3-2 circuit split over whether the civil prongs of the RICO statute allow a plaintiff to seek damages for economic harms stemming from injuries to their person.

Again, from Reisman:

During oral arguments on Tuesday, the liberal wing of the high court expressed skepticism with the CBD companies’ rendering of the case, which they said foregrounded Horn’s ingestion of the product as the source of the injury, as opposed to his firing for a positive drug test.

Lisa Blatt, an attorney for the CBD companies, told the justices that agreeing with Horn’s interpretation of the statute would open the door for virtually limitless personal injury cases under civil RICO, as long as plaintiffs could allege some connection between their ingestion of a product and a loss to their business or property: “Respondent’s rule also leaves the personal exclusion [in civil RICO] toothless, since virtually all personal injuries result in monetary loss,” Blatt said. “It is utterly implausible that Congress federalized every slip-and-fall involving RICO predicates. Personal injuries are serious and may support state tort claims, but they are not the stuff of RICO.”

On the other side, conservative justices attempted to discern how to draw a line between bona fide economic claims and personal injury claims pleaded as economic claims.

Easha Anand, arguing on behalf of Horn, said the vast majority of personal injury claims, such as those alleging pain and suffering or emotional distress, would still be excluded even if Horn was permitted to pursue his RICO claim against the CBD companies: “In your average slip-and-fall case, you’re not going to be able to prove a predicate act, let alone a pattern of predicate acts, let alone a pattern carried on through a racketeering enterprise,” Anand said.

Justice Neil Gorsuch observed, “There’s a failure to warn that this product contains ingredients that your client didn’t know about and should have known about and had a right to know about. I would have thought that that would have been kind of a classic personal injury.”

The Takeaway

This is pretty scary stuff for CBD and other hemp operators. RICO is no joke and carries very serious penalties (both civil and criminal depending on who is bringing the suit).

From the perspective of a CBD manufacturer, it seems unfair to hold the manufacturer responsible to control how its products are used and, as in this case, the implications of that use (here, an alleged economic injury).

If the Court rules that CBD and other hemp manufacturers are subject to RICO charges simply by selling their products to people who do things outside of the manufacturers’ control, it could pose an existential crisis to the industry with potentially unlimited civil (and maybe even criminal) liability. We have warned about this before.

That said, while it’s always difficult to predict how the Supreme Court will vote on any issue, I do not believe the Court will push the hemp industry to the brink. I suspect the Court will either rule that the claims in the present case are personal injury claims excluded from RICO and/or provide guidance for how lower courts should examine such “mixed” claims.

We’ll of course provide additional information once we hear from the Court. Stay tuned.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media